Telomere length in myelodysplastic syndromes

被引:45
|
作者
Rollison, Dana E. [1 ]
Epling-Burnette, P. K. [2 ]
Park, Jong Y. [1 ]
Lee, Ji-Hyun [1 ]
Park, Hyun [1 ]
Jonathan, Kristen [1 ]
Cole, Ashley L. [1 ]
Painter, Jeffrey S. [2 ]
Guerrier, Mayenha [2 ]
Melendez-Santiago, Johana [3 ]
Fulp, William [1 ]
Komrokji, Rami [4 ]
Lancet, Jeffrey [4 ]
List, Alan F. [4 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Program Immunol, Tampa, FL 33682 USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Flow Cytometry Core Facil, Tampa, FL 33682 USA
[4] Univ S Florida, H Lee Moffitt Canc Ctr, Malignant Hematol Program, Tampa, FL 33682 USA
关键词
Myelodysplastic syndromes; telomere length; hTERT; WORLD-HEALTH-ORGANIZATION; CANCER RISK; MUTATIONS; GENE; CLASSIFICATION; ASSOCIATION; EXPOSURE; COHORT; BLOOD; CELLS;
D O I
10.3109/10428194.2011.568648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between telomere length (TL) and predisposition to myelodysplastic syndromes (MDS) remains unclear. We compared peripheral blood leukocyte (PBL) TL among cases of histologically confirmed MDS (n = 65) who were treatment-naive with no prior cancer history to age-matched controls (n = 63). Relative TL was measured in PBLs and saliva by quantitative polymerase chain reaction (PCR) and in CD15+ and CD19+ cells by flow cytometry-fluorescence in situ hybridization (flow-FISH). Human telomerase reverse transcriptase gene (hTERT) mutations were assessed by PCR. After adjustment for age and sex, relative TLs were reduced in PBLs (p = 0.02), CD15+ (p = 0.01), CD19+ (p = 0.25), and saliva (p = 0.13) in MDS cases versus controls, although only the PBL and CD15+ results were statistically significant. Among MDS cases, CD15+ and CD19+ cell TLs were positively correlated (p = 0.03). PBL TL was reduced among those occupationally exposed to paints and pesticides, but was not associated with hTERT genotype. Future studies are needed to further investigate constitutional telomere attrition as a possible predisposing factor for MDS.
引用
收藏
页码:1528 / 1536
页数:9
相关论文
共 50 条
  • [1] Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome
    Poloni, Antonella
    Serrani, Federica
    Berardinelli, Eleonora
    Maurizi, Giulia
    Mariani, Marianna
    Costantini, Benedetta
    Trappolini, Silvia
    Mancini, Stefania
    Olivieri, Attilio
    Leoni, Pietro
    LEUKEMIA RESEARCH, 2013, 37 (11) : 1538 - 1544
  • [2] Significance of telomere capture in myelodysplastic syndromes
    Labib, Hany A.
    Elshorbagy, Sheren
    Elantonuy, Neveen G.
    MEDICAL ONCOLOGY, 2014, 31 (10) : 1 - 6
  • [3] Significance of telomere capture in myelodysplastic syndromes
    Hany A. Labib
    Sheren Elshorbagy
    Neveen G. Elantonuy
    Medical Oncology, 2014, 31
  • [4] Telomere Shortening and Chromosomal Instabiliity in Myelodysplastic Syndromes
    Lange, Kathrin
    Holm, Lisa
    Nielsen, Kirsten Vang
    Hahn, Andreas
    Hofmann, Winfried
    Kreipe, Hans
    Schlegelberger, Brigitte
    Goehring, Gudrun
    GENES CHROMOSOMES & CANCER, 2010, 49 (03) : 260 - 269
  • [5] Myelodysplastic Syndromes
    Odenike, Olatoyosi
    Anastasi, John
    Le Beau, Michelle M.
    CLINICS IN LABORATORY MEDICINE, 2011, 31 (04) : 763 - +
  • [6] Myelodysplastic syndromes
    Thol, F.
    Heuser, M.
    Ganser, A.
    INTERNIST, 2015, 56 (04): : 364 - 373
  • [7] Myelodysplastic syndromes and overlap syndromes
    Chang, Yoon Hwan
    BLOOD RESEARCH, 2021, 56 : 51 - 64
  • [8] Myelodysplastic syndromes
    Thol, F.
    Heuser, M.
    Ganser, A.
    INTERNIST, 2015, 56 (04): : 364 - 373
  • [9] Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation
    Ohyashiki, K
    Iwama, H
    Yahata, N
    Tauchi, T
    Kawakubo, K
    Shimamoto, T
    Ohyashiki, JH
    LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 291 - 299
  • [10] Telomere length and risk of glioma
    Walcott, Farzana
    Rajaraman, Preetha
    Gadalla, Shahinaz M.
    Inskip, Peter D.
    Purdue, Mark P.
    Albanes, Demetrius
    Orr, Esther
    De Vivo, Immaculata
    Savage, Sharon A.
    CANCER EPIDEMIOLOGY, 2013, 37 (06) : 935 - 938